Polyneuropathy in impaired glucose tolerance: Is postprandial hyperglycemia the main culprit? a mini-review

Gerontology

Volumn 59, Issue 3, 2013, Pages 193-198

  Papanas, N ^a   Ziegler, D ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Diabetes mellitus; Hyperglycemia; Impaired glucose tolerance; Peripheral neuropathy

Indexed keywords

POLYOL; PROTEIN KINASE C;

ANTIHYPERTENSIVE THERAPY; DNA DAMAGE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOLIPEMIA; IMPAIRED GLUCOSE TOLERANCE; METABOLIC SYNDROME X; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; NEUROPATHIC PAIN; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; TERTIARY CARE CENTER; WEIGHT REDUCTION;

EID: 84877874830     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000343988     Document Type: Review

References (22)

1. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes Association: Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-962
2. Papanas N, Vinik AI, Ziegler D: Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol 2011; 7: 682-690
3. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M: Prediabetes: A high-risk state for diabetes development. Lancet 2012; 379(9833):2279-2290
4. Gordon Smith A: Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy. J Peripher Nerv Syst 2012; 17(suppl 2):15-21
5. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A; KORA Study Group: Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/ KORA Augsburg Surveys S2 and S3. Diabetes Care 2008; 31: 464-469
6. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A; KORA Study Group: Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/ KORA Augsburg Surveys S2 and S3. Pain Med 2009; 10: 393-400
7. Ziegler D, Rathmann W, Meisinger C, Dickhaus T, Mielck A; KORA Study Group: Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with prediabetes and diabetes. The KORA Myocardial Infarction Registry. Eur J Pain 2009; 13: 582-587
8. Bongaerts BWC, Rathmann W, Kowall B, Herder C, Stöckl D, Meisinger C, Ziegler D: Post-challenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study. Diabetes Care 2012; 35: 1891-1893
9. Hughes RA, Umapathi T, Gray IA, Gregson NA, Noori M, Pannala AS, Proteggente A, Swan AV: A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004; 127: 1723-1730
10. de Neeling JN, Beks PJ, Bertelsmann FW, Heine RJ, Bouter LM: Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study. Diabet Med 1996; 13: 960-966
11. Dyck PJ, Clark VM, Overland CJ, Davies JL, Pach JM, Dyck PJ, Klein CJ, Rizza RA, Melton LJ 3rd, Carter RE, Klein R, Litchy WJ: Impaired glycemia and diabetic polyneuropathy: The OC IG Survey. Diabetes Care 2012; 35: 584-591
12. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen MR: What does postprandial hyperglycaemia mean? Diabet Med 2004; 21: 208-213
13. Adolphe JL, Drew MD, Huang Q, Silver TI, Weber LP: Postprandial impairment of flowmediated dilation and elevated methylglyoxal after simple but not complex carbohydrate consumption in dogs. Nutr Res 2012; 32: 278-284
14. Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, Sauer SK, Eberhardt M, Schnölzer M, Lasischka F, Neuhuber WL, Kichko TI, Konrade I, Elvert R, Mier W, Pirags V, Lukic IK, Morcos M, Dehmer T, Rabbani N, Thornalley PJ, Edelstein D, Nau C, Forbes J, Humpert PM, Schwaninger M, Ziegler D, Stern DM, Cooper ME, Haberkorn U, Brownlee M, Reeh PW, Nawroth PP: Methylglyoxal modification of Na(v)1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med 2012; 18: 926-933
15. Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL: Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 2009; 58: 2376-2385
16. Putz Z, Tabák AG, Tóth N, Istenes I, Németh N, Gandhi RA, Hermányi Z, Keresztes K, Jermendy G, Tesfaye S, Kempler P: Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009; 32: 181-183
17. Tavakoli M, Marshall A, Pitceathly R, Fadavi H, Gow D, Roberts ME, Efron N, Boulton AJ, Malik RA: Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol 2010; 223: 245-250
18. Ziegler D, Papanas N, Rathmann W, Heier M, Scheer M, Meisinger C; KORA Study Group: Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes. The KORA F4 survey. Diabetes Metab Res Rev 2012;28:592-697
19. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, Hamwi J, Pollari D, Bixby B, Howard J, Singleton JR: Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006; 29: 1294-1299
20. Singleton JR, Bixby B, Feldman EL: Diet and exercise counseling alone does not prevent long term neuropathy progression in IGTN (abstract). Neurology 2007; 68:A410
21. Gong Q, Gregg EW, Wang J, An Y, Zhang P, Yang W, Li H, Li H, Jiang Y, Shuai Y, Zhang B, Zhang J, Gerzoff RB, Roglic G, Hu Y, Li G, Bennett PH: Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 2011; 54: 300-307
22. Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, Samigullin R, Tritschler H, Munzel U, Maus J, Schütte K, Dyck PJ: Efficacy and safety of antioxidant treatment with --lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 2011; 34: 2054-2060.